FrancophonIA/ELRC3.0 huggingface dataset:
English: Vizarsin 100 mg film-coated tablets are available in boxes of 1 film-coated tablet in blisters and also in boxes of 4 x 1, 8 x 1 or 12 x 1 film-coated tablet in a perforated unit dose blisters.
Danish: Vizarsin 100 mg filmovertrukne tabletter findes i æsker med 1 filmovertrukket tablet som blisterpakning og ligeledes i æsker med 4 x 1, 8 x 1 eller 12 x 1 filmovertrukket tablet som perforerede enkeltdosis-blisterpakninger.
English: Retinal haemorrhage, Arteriosclerotic retinopathy, Retinal disorder, Glaucoma, Visual field defect, Diplopia,
Danish: Non-arteritis anterior iskæmisk opticusneuropati (NAION)*, vaskulær okklusion i retina*, blødning i retina, arteriosklerotisk retinopati, retinal sygdom, glaukom, synsfeltdefekt,
English: What Vizarsin looks like and contents of the pack White to almost white, round, slightly biconvex tablets, with possible darker spots.
Danish: Udseende og pakningsstørrelser Hvide til næsten hvide, runde, let hvælvede tabletter evt. med mørkere pletter.
English: fl\\
Danish: SN:
English: Vizarsin 100 mg film-coated tablets Sildenafil
Danish: Vizarsin 100 mg filmovertrukne tabletter Sildenafil
English: Vizarsin 50 mg film-coated tablets are available in boxes of 1 film-coated tablet in blisters and also in boxes of 4 x 1, 8 x 1 or 12 x 1 film-coated tablet in a perforated unit dose blisters.
Danish: Vizarsin 50 mg filmovertrukne tabletter findes i æsker med 1 filmovertrukket tablet som blisterpakning og ligeledes i æsker med 4 x 1, 8 x 1 eller 12 x 1 filmovertrukket tablet som perforerede enkeltdosis-blisterpakninger.
English: Vizarsin 25 mg orodispersible tablets Sildenafil
Danish: Vizarsin 25 mg smeltetabletter Sildenafil
English: Vizarsin 50 mg film-coated tablets Sildenafil
Danish: Vizarsin 50 mg filmovertrukne tabletter Sildenafil
English: Vizarsin orodispersible tablets are available in boxes of 1 orodispersible tablet in blisters and also in boxes of 2 x 1, 4 x 1, 8 x 1 or 12 x 1 orodispersible tablet in a perforated unit dose blisters.
Danish: Vizarsin smeltetabletter findes i æsker med 1 smeltetablet i blisterpakning og i æsker med 2 x 1, 4 x 1, 8 x 1 eller 12 x 1 smeltetablet i en perforeret enkeltdosisblister.
English: Vizarsin 100 mg orodispersible tablets Sildenafil
Danish: Vizarsin 100 mg smeltetabletter Sildenafil
English: 1 orodispersible tablet: EU/1/09/551/013 2 x 1 orodispersible tablet: EU/1/09/551/014 4 x 1 orodispersible tablet: EU/1/09/551/015 8 x 1 orodispersible tablet: EU/1/09/551/016 12 x 1 orodispersible tablet: EU/1/09/551/017
Danish: 1 smeltetablet: EU/1/09/551/013 2 x 1 smeltetablet: EU/1/09/551/014 4 x 1 smeltetablet: EU/1/09/551/015 8 x 1 smeltetablet: EU/1/09/551/016 12 x 1 smeltetablet: EU/1/09/551/017
English: Vizarsin 50 mg orodispersible tablets Sildenafil
Danish: Vizarsin 50 mg smeltetabletter Sildenafil
English: 2 x 1 orodispersible tablet: EU/1/09/551/019 4 x 1 orodispersible tablet: EU/1/09/551/020 8 x 1 orodispersible tablet: EU/1/09/551/021 12 x 1 orodispersible tablet: EU/1/09/551/022 24 x 1 orodispersible tablet: EU/1/09/551/028
Danish: 2 x 1 smeltetablet: EU/1/09/551/019 4 x 1 smeltetablet: EU/1/09/551/020 8 x 1 smeltetablet: EU/1/09/551/021 12 x 1 smeltetablet: EU/1/09/551/022 24 x 1 smeltetablet: EU/1/09/551/028
English: 2 x 1 orodispersible tablet: EU/1/09/551/024 4 x 1 orodispersible tablet: EU/1/09/551/025 8 x 1 orodispersible tablet: EU/1/09/551/026 12 x 1 orodispersible tablet: EU/1/09/551/027 24 x 1 orodispersible tablet: EU/1/09/551/029
Danish: 2 x 1 smeltetablet: EU/1/09/551/024 4 x 1 smeltetablet: EU/1/09/551/025 8 x 1 smeltetablet: EU/1/09/551/026 12 x 1 smeltetablet: EU/1/09/551/027 24 x 1 smeltetablet: EU/1/09/551/029
English: Vizarsin 100 mg orodispersible tablets
Danish: Vizarsin 100 mg smeltetabletter
English: 2 x 1 orodispersible tablet: EU/1/09/551/014 4 x 1 orodispersible tablet: EU/1/09/551/015 8 x 1 orodispersible tablet: EU/1/09/551/016 12 x 1 orodispersible tablet: EU/1/09/551/017
Danish: 2 x 1 smeltetablet: EU/1/09/551/014 4 x 1 smeltetablet: EU/1/09/551/015 8 x 1 smeltetablet: EU/1/09/551/016 12 x 1 smeltetablet: EU/1/09/551/017
English: Vizarsin 25 mg orodispersible tablets
Danish: Vizarsin 25 mg smeltetabletter
English: Vizarsin 50 mg orodispersible tablets
Danish: Vizarsin 50 mg smeltetabletter
English: Nasal congestion
Danish: forlænget erektion
English: What Vizarsin looks like and contents of the pack Vizarsin 100 mg film-coated tablets are white, oblong and marked “100” on one side.
Danish: Vizarsin 100 mg filmovertrukne tabletter er hvide, aflange tabletter og mærket med ”100” på den ene side.
English: Consistent with its known effects on the nitric oxide/cGMP pathway (see section 5.1), sildenafil was shown to potentiate the hypotensive effects of nitrates, and its co-administration with nitric oxide donors or nitrates in any form is therefore contraindicated (see section 4.3).
Danish: Samtidig anvendelse af nitrogenoxiddonorer eller nitrater i en hvilken som helst form er derfor kontraindiceret (se pkt.
English: What Vizarsin looks like and contents of the pack Vizarsin 25 mg film-coated tablets are white, oblong and marked “25” on one side.
Danish: Vizarsin 25 mg filmovertrukne tabletter er hvide, aflange tabletter og mærket med ”25” på den ene side.
English: Annex I List of the names, pharmaceutical form(s), strength(s) of the medicinal product(s), route(s) of administration, marketing authorisation holder(s) in the member states
Danish: Bilag I Fortegnelse over lægemidlernes navne, lægemiddelformer, styrker, administrationsveje og indehavere af markedsføringstilladelser i medlemsstaterne
English: 28703 San Sebastian de los Reyes (Madrid) Spain
Danish: 28703 San Sebastian de los Reyes (Madrid) Spanien
English: 747 70 Opava-Komárov Czech Republic
Danish: 747 70 Opava-Komárov Tjekkiet
English: 0.10 g / 0.80 g oral solution
Danish: 0,10 g/0,80 g oral opløsning
English: Ferraz 80, 5º 28008 Madrid Spain
Danish: Ferraz 80, 5º 28008 Madrid Spanien
English: ERGODAVUR GOTAS 1 mg (monodose suchet)
Danish: ERGODAVUR GOTAS 1 mg (enkeltdosis suchet)
English: Czech Republic TEVA Czech Industries s.r.o.
Danish: TEVA Czech Industries s.r.o.
English: Arzneimittelvertriebs GmbH, Anton Anderer Platz 6/1, A-1210 Vienna Austria
Danish: Arzneimittelvertriebs GmbH, Anton Anderer Platz 6/1, A-1210 Wien Østrig
English: powder for oral solution for single dose
Danish: pulver til oral opløsning som enkeltdosis
English: ARKOLEON 11, KATO PATISSIA, 10445 Greece
Danish: ARKOLEON 11, KATO PATISSIA, 10445
English: FINIXFARM EPE DERVENAKION 38 & SAHINI, GERAKAS, 15344 Greece
Danish: FINIXFARM EPE DERVENAKION 38 & SAHINI, GERAKAS, 15344 Grækenland
English: ANTOR LTD P. MAVROMIHALI 1 VRILISSIA 15235 Greece
Danish: ANTOR LTD P. MAVROMIHALI 1 VRILISSIA 15235 Grækenland
English: ARGONAFTWN 22, ARGYROUPOLI, 16452 Greece
Danish: ARGONAFTWN 22, ARGYROUPOLI, 16452 Grækenland
English: G. KORONIS DILOU 9, PERISTERI, ATTIKIS, 12134 Greece
Danish: G. KORONIS DILOU 9, PERISTERI, ATTIKIS, 12134
English: 6MG/SINGLE DOSE
Danish: 6 mg/ENKELT DOSIS
English: ISKEDYL, comprimé 0.60 mg / 4.80 mg
Danish: ISKEDYL FORT, tablet 2,40 mg/19,20 mg
English: ISKEDYL FORT, comprimé
Danish: Iskedyl Fort
English: 2.5 mg (1:1:1) prolonged-release capsule, soft
Danish: Ergomed - depotkapsler 2,5 mg (1:1:1) depotkapsler, blød oral anvendelse
English: ISKEDYL, solution buvable en flacon
Danish: ISKEDYL, oral opløsning i hætteglas
English: 3 mg
Danish: 3 mg/kap.
English: ISKEDYL, solution injectable en ampoule solution for injection IV/IM
Danish: ISKEDYL, injektionsvæske ampul injektionsvæske
English: Capsule hard
Danish: 3 mg hård kapsel
English: 1mg/ml
Danish: IV/IM
English: Iskedyl Fort tablets
Danish: ISKEDYL, tablet
English: This summary was last updated in November 2016.
Danish: Dette sammendrag blev sidst ajourført i november 2016.
English: The strains of bacteria in the vaccine have these proteins but do not produce the toxins that cause the disease.
Danish: Bakteriestammerne i vaccinen har disse proteiner, men producerer ikke de toksiner, der forårsager sygdommen.
English: Two studies used the F4 strain while the other two used the F18 strain.
Danish: To undersøgelser anvendte F4-stammen, mens de to øvrige anvendte F18-stammen.
English: This will help protect the pigs against the infection and reduce the risk of disease.
Danish: Dette vil hjælpe svinene med at bekæmpe infektionen og reducere sygdomsrisikoen.
English: The vaccine reduced the number of pigs with moderate to severe diarrhoea compared to non-vaccinated pigs.
Danish: Vaccinen reducerede antallet af svin med moderat til svær diarré sammenholdt med ikke-vaccinerede svin.
English: E. coli O8:K87 / O141:K94 vaccine (live)
Danish: E. coli O8:K87/O141:K94-vaccine (levende)
English: This is more likely to occur at weaning time when the piglet no longer receives protecting antibodies through the sow's milk.
Danish: Dette er mere sandsynligt ved fravænning, hvor smågrisene ikke længere får beskyttende antistoffer gennem soens modermælk.
English: The full EPAR for Coliprotec F4/F18 can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Coliprotec F4/F18 findes på agenturets websted under: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: Personal protective equipment consisting of protective disposable gloves and safety glasses should be worn when handling the vaccine.
Danish: Der skal anvendes personligt sikkerhedsudstyr bestående af engangsbeskyttelseshandsker og sikkerhedsbriller ved håndtering af vaccinen.
English: The effectiveness of the vaccine was studied in four laboratory studies in pigs that looked chiefly at the incidence, severity and duration of diarrhoea as well as the presence of disease-causing E. coli in the animals' excrement.
Danish: Vaccinens virkning er blevet undersøgt i fire laboratorieundersøgelser hos svin, der primært så på forekomsten, sværhedsgraden og varigheden af diarréen samt tilstedeværelsen af sygdomsfremkaldende E. coli i dyrenes afføring.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Coliprotec F4/F18's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Agenturets Udvalg for Lægemidler til Dyr (CVMP) konkluderede, at fordelene ved Coliprotec F4/F18 opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: The withdrawal period for meat from pigs treated with Coliprotec F4/F18 is ‘zero' days, which means there is no mandatory waiting time.
Danish: Tilbageholdelsestiden for kød fra svin, der behandles med Coliprotec F4/F18, er "nul" dage, hvilket vil sige, at der ikke er nogen påkrævet ventetid.
English: Two studies showed the vaccine starts to be effective 7 days after vaccination and two studies showed protection lasts for 21 days after vaccination.
Danish: To undersøgelser viste, at vaccinens virkning indtræder 7 dage efter vaccination, og to undersøgelser viste, at den varer i 21 dage efter vaccination.
English: The European Commission granted a marketing authorisation valid throughout the EU for Coliprotec F4/F18 on 9 January 2017.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Coliprotec F4/F18 den 09.01.2017.
English: Although E. coli bacteria are naturally found in the gut, some strains (known as enterotoxigenic strains) produce toxins that cause diarrhoea and can result in dehydration, weight loss and occasionally death of the animal.
Danish: Selvom E. coli-bakterier forekommer naturligt i tarmsystemet, producerer visse stammer (der kaldes enterotoksigene stammer) toksiner, der kan forårsage diarré, og som kan medføre dehydrering, vægttab og indimellem dødsfald blandt dyrene.
English: In case of spillage onto skin, the affected area should be rinsed with water and medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Danish: I tilfælde af spild på huden skal det berørte område skylles med vand, og der skal straks søges lægehjælp, og indlægssedlen eller etiketten skal vises til lægen.
English: The vaccine starts to be effective 7 days after vaccination and protection lasts for 21 days after vaccination.
Danish: Vaccinens beskyttende virkning indtræder 7 dage efter vaccination og varer i 21 dage efter vaccinationen.
English: Coliprotec F4/F18 contains two strains of live E. coli bacteria (O8:K87 and O141:K94) which do not produce toxins that cause disease.
Danish: Coliprotec F4/F18 indeholder to stammer af levende E. coli-bakterier (O8:K87 og O141:K94), som ikke producerer toksiner, der forårsager sygdom.
English: In the future, if the animals are exposed to disease-causing bacteria with the F4 or F18 proteins, the immune system will be able to respond more quickly.
Danish: Hvis dyret efterfølgende igen udsættes for sygdomsfremkaldende bakterier med F4- eller F18-proteiner, vil immunsystemet reagere hurtigere.
English: Pigs aged 17 - 18 days were vaccinated with Coliprotec F4/F18 and then artificially infected with E. coli strains.
Danish: Svin i alderen 17-18 dage blev vaccineret med Coliprotec F4/F18 og derefter kunstigt smittet med E. coli-stammer.
English: The types of E. coli associated with post-weaning diarrhoea often produce proteins called F4 and F18 on their outer coat that allows them to attach to the cells of the gut.
Danish: De typer af E. coli, der er forbundet med fravænningsdiarré, producerer ofte proteiner, der kaldes F4 og F18, på deres overflade, og det sætter dem i stand til at binde sig til cellerne i tarmsystemet.
English: This is a summary of the European public assessment report (EPAR) for Coliprotec F4/F18.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Coliprotec F4/F18.
English: When Coliprotec F4/F18 is given to pigs, the animals' immune system recognises the bacteria as ‘foreign' and makes antibodies against them.
Danish: Når Coliprotec F4/F18 gives til svin, registrerer dyrenes immunsystem bakterierne som "fremmede" og reagerer ved at danne antistoffer mod dem.
English: In case of accidental ingestion, medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Danish: Ved utilsigtet indtagelse skal der straks søges lægehjælp, og indlægssedlen eller etiketten skal vises til lægen.
English: Coliprotec F4/F18 is a vaccine.
Danish: Coliprotec F4/F18 er en vaccine.
English: Coliprotec F4/F18 is available as a lyophilisate (a freeze-dried pellet) which is made up into a suspension with water to be given by mouth.
Danish: Coliprotec F4/F18 fås som lyofilisat (frysetørret pulver), der blandes med vand til en suspension, som gives gennem munden.
English: There are currently no known side effects associated with Coliprotec F4/F18.
Danish: Der er i øjeblikket ingen kendte bivirkninger forbundet med Coliprotec F4/F18.
English: Coliprotec F4/F18 is given by mouth to pigs as a single dose either as a drench or by addition to the drinking water.
Danish: Coliprotec F4/F18 gives gennem munden til svin som en enkeltdosis enten som massevaccination eller via drikkevandssystemet.
English: Coliprotec F4/F18 is a vaccine used to protect pigs from 18 days of age against post-weaning diarrhoea caused by E. coli.
Danish: Coliprotec F4/F18 er en vaccine, der anvendes til svin fra 18 dages-alderen til behandling af E.
English: What is Coliprotec F4/F18 and what is it used for?
Danish: Hvad er Coliprotec F4/F18, og hvad anvendes det til?
English: It is not intended to provide practical advice on how to use Coliprotec F4/F18.
Danish: Det er ikke en praktisk vejledning i, hvordan Coliprotec F4/F18 bør anvendes.
English: For more information about treatment with Coliprotec F4/F18, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Danish: Hvis du som ejer eller ansvarlig for dyret ønsker yderligere oplysninger om behandling med Coliprotec F4/F18, kan du læse indlægssedlen eller kontakte din dyrlæge eller dit apotek.
English: For practical information about using Coliprotec F4/F18, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Danish: Hvis du som ejer eller ansvarlig for dyret ønsker praktisk vejledning om anvendelsen af Coliprotec F4/F18, kan du læse indlægssedlen eller kontakte din dyrlæge eller dit apotek.
English: What are the risks associated with Coliprotec F4/F18?
Danish: Hvilke risici er der forbundet med Coliprotec F4/F18?
English: Why is Coliprotec F4/F18 approved?
Danish: Hvorfor er Coliprotec F4/F18 blevet godkendt?
English: Other information about Coliprotec F4/F18?
Danish: Andre oplysninger om Coliprotec F4/F18
English: How is Coliprotec F4/F18 used?
Danish: Hvordan anvendes Coliprotec F4/F18?
English: How does Coliprotec F4/F18 work?
Danish: Hvordan virker Coliprotec F4/F18?
English: What benefits of Coliprotec F4/F18 have been shown in studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Coliprotec F4/F18?
English: Vosevi must not be used together with certain medicines such as:
Danish: Vosevi må ikke anvendes sammen med visse andre lægemidler, f.eks.:
English: The recommended dose is one tablet taken once a day with food for 8 or 12 weeks.
Danish: Den anbefalede dosis er én tablet én gang dagligt, der tages sammen med mad, i 8 eller 12 uger.
English: This is a summary of the European public assessment report (EPAR) for Vosevi.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Vosevi.
English: Other information about Vosevi
Danish: Andre oplysninger om Vosevi
English: The full EPAR for Vosevi can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Vosevi findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Sofosbuvir/velpatasvir has been authorised in the EU as Epclusa since July 2016.
Danish: Sofosbuvir/velpatasvir har været godkendt i EU under navnet Epclusa siden juli 2016.
English: What measures are being taken to ensure the safe and effective use of Vosevi?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Vosevi?
English: What is Vosevi and what is it used for?
Danish: Hvad er Vosevi, og hvad anvendes det til?
English: It is not intended to provide practical advice on how to use Vosevi.
Danish: Det er ikke en praktisk vejledning i, hvordan Vosevi bør anvendes.
English: The European Medicines Agency therefore decided that Vosevi's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede derfor, at fordelene ved Vosevi opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: The most common side effects with Vosevi (which may affect more than 1 in 10 people) are headache, nausea (feeling sick) and diarrhoea.
Danish: De hyppigste bivirkninger ved Vosevi (som kan forekomme hos mere end 1 ud af 10 personer) er hovedpine, kvalme og diarré.
English: Why is Vosevi approved?
Danish: Hvorfor blev Vosevi godkendt?
English: The clearance rates with Vosevi were typically above 95%.
Danish: Eliminationsraten (fjernelsesraten) ved Vosevi var generelt over 95 %.
English: What are the risks associated with Vosevi?
Danish: Hvilke risici er der forbundet med Vosevi?
English: Regarding safety, Vosevi was well tolerated with no major safety concern emerging.
Danish: Desuden tåles Vosevi godt, uden at der er opstået nævneværdige sikkerhedsproblemer.
English: This study is being carried out in light of data suggesting that patients treated with medicines belonging to the same class as Vosevi who have had liver cancer could be at risk of their cancer returning early.
Danish: Denne undersøgelse gennemføres på baggrund af data, der indikerer, at patienter, som behandles med lægemidler i samme klasse som Vosevi, og som har haft leverkræft, kunne være i risiko for, at deres kræft vender hurtigt tilbage.
English: By blocking these proteins, Vosevi stops the hepatitis C virus from multiplying and infecting new cells.
Danish: Ved at blokere for disse proteiner forhindrer Vosevi hepatitis C-virusset i at formere sig og inficere nye celler.
English: Sofosbuvir blocks the action of an enzyme (a type of protein) called ‘NS5B RNA-dependent RNA polymerase', velpatasvir targets a protein called ‘NS5A', while voxilaprevir blocks an enzyme called NS3/4A protease.
Danish: Sofosbuvir blokerer for effekten af et enzym (en type protein), der kaldes "NS5B RNA-afhængig RNA-polymerase”, velpatasvir blokerer for proteinet NS5A, mens voxilaprevir blokerer for enzymet NS3/4A-protease.
English: Vosevi is available as tablets containing 400 mg sofosbuvir, 100 mg velpatasvir and 100 mg voxilaprevir.
Danish: Vosevi fås som tabletter, der indeholder 400 mg sofosbuvir, 100 mg velpatasvir og 100 mg voxilaprevir.
English: For the full list of side effects and restrictions with Vosevi, see the package leaflet.
Danish: Den fuldstændige liste over bivirkninger og begrænsninger ved Vosevi fremgår af indlægssedlen.
English: The fact that Vosevi can be given for 8 weeks (instead of the usual 12) to patients who do not have liver cirrhosis is considered an advantage.
Danish: Det vurderes at være en fordel, at Vosevi kan gives i 8 uger (i stedet for de sædvanlige 12 uger) til patienter, der ikke har skrumpelever.
English: For more information about treatment with Vosevi, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Vosevi, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: Vosevi can only be obtained with a prescription, and treatment should be started and monitored by a doctor experienced in the management of patients with hepatitis C virus infection.
Danish: Vosevi udleveres kun efter recept, og behandlingen bør iværksættes og overvåges af en læge med erfaring i behandling af patienter, der er smittet med hepatitis C-virus.
English: The company that markets Vosevi will carry out a study in patients who previously have had liver cancer to evaluate the risk of liver cancer returning after treatment with direct-acting antivirals.
Danish: Den virksomhed, der markedsfører Vosevi, vil gennemføre en undersøgelse af patienter, der tidligere har haft leverkræft, for at evaluere risikoen for, at leverkræften vender tilbage efter behandling med direkte virkende antivirale lægemidler.
English: • carbamazepine, phenobarbital, phenytoin (medicines for epilepsy);
Danish: • carbamazepin, phenobarbital, phenytoin (lægemidler mod epilepsi)
English: The active substances in Vosevi (sofosbuvir, velpatasvir and voxilaprevir) block three proteins essential for the hepatitis C virus to multiply.
Danish: De aktive stoffer i Vosevi (sofosbuvir, velpatasvir og voxilaprevir) blokerer for tre proteiner, som hepatitis C-virusset behøver for at formere sig.
English: The duration of treatment depends on whether patients have liver cirrhosis (scarring of the liver) or have received treatment with other direct-acting antivirals.
Danish: Behandlingens varighed afhænger af, om patienterne har såkaldt levercirrose (skrumpelever, dvs. ardannelse i leveren) eller har fået behandling med andre direkte virkende antivirale lægemidler.
English: Vosevi contains the active substances sofosbuvir, velpatasvir and voxilaprevir.
Danish: Vosevi indeholder de aktive stoffer sofosbuvir, velpatasvir og voxilaprevir.
English: • rifampicin, rifabutin (antibiotics usually used to treat tuberculosis);
Danish: • rifampicin, rifabutin (antibiotika, typisk til behandling af tuberkulose)